CAD 0.94
(2.17%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.66 Million USD | 10.74% |
2022 | 6.67 Million USD | 50.01% |
2021 | 4.44 Million USD | 58.27% |
2020 | 2.81 Million USD | -40.52% |
2019 | 4.72 Million USD | 11.56% |
2018 | 4.23 Million USD | 287.43% |
2017 | 1.09 Million USD | 15.44% |
2016 | 947.17 Thousand USD | 91.59% |
2015 | 494.38 Thousand USD | -82.45% |
2014 | 2.81 Million USD | 376.99% |
2013 | 590.61 Thousand USD | -37.83% |
2012 | 949.94 Thousand USD | 57.34% |
2011 | 603.75 Thousand USD | 6.97% |
2010 | 564.43 Thousand USD | 230.06% |
2009 | 171.01 Thousand USD | 261.5% |
2008 | 47.3 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.9 Million USD | 0.0% |
2024 Q3 | 2.74 Million USD | 43.99% |
2023 Q3 | 1.37 Million USD | -12.66% |
2023 FY | 7.39 Million USD | 10.74% |
2023 Q2 | 1.57 Million USD | -7.95% |
2023 Q1 | 1.7 Million USD | -47.08% |
2023 Q4 | 1.74 Million USD | 27.38% |
2022 Q1 | 1.67 Million USD | 15.59% |
2022 Q3 | 1.15 Million USD | -34.61% |
2022 Q4 | 3.22 Million USD | 180.09% |
2022 Q2 | 1.76 Million USD | 5.15% |
2022 FY | 6.67 Million USD | 50.01% |
2021 Q3 | 1.33 Million USD | 54.87% |
2021 FY | 4.44 Million USD | 58.27% |
2021 Q4 | 1.44 Million USD | 8.25% |
2021 Q1 | 1.01 Million USD | 106.2% |
2021 Q2 | 864.03 Thousand USD | -15.2% |
2020 FY | 2.81 Million USD | -40.52% |
2020 Q4 | 494.14 Thousand USD | -48.86% |
2020 Q2 | 622.5 Thousand USD | -14.5% |
2020 Q3 | 966.28 Thousand USD | 55.23% |
2020 Q1 | 728.09 Thousand USD | 58.86% |
2019 Q2 | 1.64 Million USD | 47.97% |
2019 Q4 | 458.33 Thousand USD | -69.68% |
2019 FY | 4.72 Million USD | 11.56% |
2019 Q1 | 1.11 Million USD | -36.78% |
2019 Q3 | 1.51 Million USD | -8.07% |
2018 Q3 | 128.16 Thousand CAD | 31.5% |
2018 FY | 4.23 Million USD | 287.43% |
2018 Q4 | 1.75 Million USD | 1271.67% |
2018 Q2 | 97.46 Thousand USD | 33.53% |
2018 Q1 | 72.99 Thousand USD | -25.45% |
2017 Q3 | 1.51 Million USD | 856.21% |
2017 Q2 | 157.94 Thousand USD | 23.85% |
2017 Q1 | 127.52 Thousand USD | -66.51% |
2017 FY | 1.09 Million USD | 15.44% |
2017 Q4 | 97.91 Thousand USD | -93.52% |
2016 Q3 | 187.67 Thousand USD | -71.23% |
2016 FY | 947.17 Thousand USD | 91.59% |
2016 Q2 | 652.34 Thousand USD | 1060.29% |
2016 Q4 | 380.74 Thousand USD | 102.87% |
2016 Q1 | 56.22 Thousand CAD | 18.25% |
2015 Q1 | 208 Thousand USD | -2.94% |
2015 Q4 | 47.54 Thousand USD | 119.71% |
2015 Q3 | -241.21 Thousand USD | -173.39% |
2015 Q2 | 328.67 Thousand USD | 58.02% |
2015 FY | 494.38 Thousand USD | -82.45% |
2014 Q1 | 92.06 Thousand USD | 23.95% |
2014 FY | 2.81 Million USD | 376.99% |
2014 Q2 | 53.3 Thousand USD | -42.1% |
2014 Q3 | 189.63 Thousand USD | 255.78% |
2014 Q4 | 214.29 Thousand USD | 13.0% |
2013 Q1 | 172.72 Thousand USD | -2.68% |
2013 FY | 590.61 Thousand USD | -37.83% |
2013 Q4 | 74.27 Thousand USD | -53.29% |
2013 Q3 | 159.01 Thousand USD | 92.22% |
2013 Q2 | 82.72 Thousand USD | -52.11% |
2012 Q3 | -1.06 Million USD | -366.57% |
2012 FY | 949.94 Thousand USD | 57.34% |
2012 Q2 | 399.38 Thousand USD | -72.44% |
2012 Q1 | 1.44 Million USD | 1284.13% |
2012 Q4 | 177.49 Thousand USD | 116.67% |
2011 Q3 | 139.72 Thousand USD | -25.97% |
2011 Q4 | 104.7 Thousand USD | -25.06% |
2011 Q1 | 43.02 Thousand USD | -16.55% |
2011 FY | 603.75 Thousand USD | 6.97% |
2011 Q2 | 188.73 Thousand USD | 338.68% |
2010 Q3 | 397.79 Thousand USD | 485.53% |
2010 Q2 | 67.93 Thousand USD | 91.61% |
2010 Q1 | 35.45 Thousand USD | -43.92% |
2010 FY | 564.43 Thousand USD | 230.06% |
2010 Q4 | 51.55 Thousand USD | -87.04% |
2009 Q4 | 63.22 Thousand USD | -28.45% |
2009 Q1 | 7970.54 USD | 41.33% |
2009 FY | 171.01 Thousand USD | 261.5% |
2009 Q3 | 88.35 Thousand USD | 69.7% |
2009 Q2 | 52.06 Thousand USD | 553.26% |
2008 FY | 47.3 Thousand USD | 0.0% |
2008 Q4 | 5639.75 USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | -7052.976% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 0.414% |
Blueberries Medical Corp. | 84.22 Thousand CAD | -13753.037% |
The BC Bud Corporation | 1.28 Million CAD | -809.422% |
BioNxt Solutions Inc. | 6.73 Million CAD | -73.123% |
CordovaCann Corp. | 3.86 Million CAD | -202.148% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | -172.409% |
Captor Capital Corp. | 16.28 Million CAD | 28.341% |
City View Green Holdings Inc. | 705.7 Thousand CAD | -1553.333% |
1CM Inc. | 7.3 Million CAD | -59.659% |
Global Hemp Group Inc. | 551.7 Thousand CAD | -2014.836% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | -142.692% |
IM Cannabis Corp. | 22.63 Million CAD | 48.46% |
Lobe Sciences Ltd. | 4.13 Million CAD | -182.36% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | -2874.82% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -19346.2% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | -559.935% |
Ovation Science Inc. | 54.1 Thousand CAD | -21466.95% |
Pharmadrug Inc. | 1.33 Million CAD | -773.978% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | -793.799% |
RAMM Pharma Corp. | 7.48 Million CAD | -55.977% |
RIV Capital Inc. | 21.1 Million CAD | 44.709% |
Revive Therapeutics Ltd. | 3.28 Million CAD | -255.104% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 69.1% |
SLANG Worldwide Inc. | 24.6 Million CAD | 52.581% |
1933 Industries Inc. | 5.12 Million CAD | -127.652% |
Red Light Holland Corp. | 2.02 Million CAD | -477.476% |
Top Strike Resources Corp. | 3.63 Million CAD | -221.27% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 3883.038% |
Adastra Holdings Ltd. | 9.36 Million CAD | -24.647% |